Wells Fargo & Company »

Apogee Therapeutics shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Apogee Therapeutics (APGE) shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Apogee Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Apogee Therapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apogee Therapeutics by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2025-09-30 $874k 22k 39.73
2025-06-30 $732k 17k 43.43
2025-03-31 $676k 18k 37.36
2024-12-31 $802k 18k 45.30
2024-09-30 $5.8M 98k 58.74
2024-06-30 $456k 12k 39.35
2024-03-31 $892k 13k 66.45
2023-12-31 $164k 5.9k 27.94
2023-09-30 $94k 4.4k 21.30